Literature DB >> 17669635

Cellular transcription modulator SMARCE1 binds to HBV core promoter containing naturally occurring deletions and represses viral replication.

Hong Pan1, Dan Dan Niu, Huixing Feng, Lisa F P Ng, Ee Chee Ren, Wei Ning Chen.   

Abstract

Suppression of hepatitis B virus (HBV) replication, a causative agent for chronic hepatitis, is an effective approach to controlling disease progression. Host factors have a significant effect on viral replication efficiency and need to be better characterized. We have reported association between clinical virus load and deletions in HBV viral promoter. We showed here that HBV genome with such deletions led to decreased replication compared with wild type virus. Consistently, the promoter with deletion showed lower activity. A cellular transcription regulator recognizing the promoter with deletion was revealed in gel shift assay and subsequently identified as SMARCE 1 through DNA-protein array assay. The ability of SMARCE 1 in modulating the replication efficiency of HBV was further demonstrated. Taken together, our studies show a direct dependence of HBV on a host factor to modulate its replication efficiency, and provided a new platform for molecular characterization of mechanisms of disease outcome as a result of binding of new transcription factors to rearranged promoter sequences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669635     DOI: 10.1016/j.bbadis.2007.06.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.

Authors:  Yu Cheng; Weiwu Shi; Xudong Cui; Lei Sun; Yi Nan; Hong Yao; Jian Fan; LiYing Zhu; Lei Yu
Journal:  Dis Markers       Date:  2022-04-18       Impact factor: 3.464

2.  miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma.

Authors:  Hong-Jie Wu; Ya Zhuo; Yan-Cai Zhou; Xin-Wei Wang; Yan-Ping Wang; Chang-Yun Si; Xin-Hong Wang
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

3.  Variants in the SMARCA4 gene was associated with coronary heart disease susceptibility in Chinese han population.

Authors:  Xuan Guo; Xiaohong Wang; Yuan Wang; Chunyan Zhang; Xiaohui Quan; Yan Zhang; Shan Jia; Weidong Ma; Yajie Fan; Congxia Wang
Journal:  Oncotarget       Date:  2017-01-31

4.  MicroRNA-802 induces hepatitis B virus replication and replication through regulating SMARCE1 expression in hepatocellular carcinoma.

Authors:  Yuanyuan Wang; Jingmei Cao; Shiyun Zhang; Lei Sun; Yi Nan; Hong Yao; Jian Fan; Li Ying Zhu; Lei Yu
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

5.  Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis.

Authors:  Rong Zhong; Li Liu; Yao Tian; Ying Wang; Jing Tian; Bei-bei Zhu; Wei Chen; Jia-ming Qian; Li Zou; Min Xiao; Na Shen; Hong Yang; Jiao Lou; Qian Qiu; Jun-tao Ke; Xing-hua Lu; Zhen-ling Wang; Wei Song; Ti Zhang; Hui Li; Li Wang; Xiao-ping Miao
Journal:  Sci Rep       Date:  2014-02-21       Impact factor: 4.379

6.  The genetic polymorphisms of ZC3HC1 and SMARCA4 are associated with hypertension risk.

Authors:  Huijun Ma; Yongjun He; Mei Bai; Linhao Zhu; Xue He; Li Wang; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2019-09-10       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.